Retraction: Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction

Editorial Office, Frontiers

doi:10.3389/fphar.2025.1575629

RETRACTION article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1575629

Retraction: Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction

Provisionally accepted

Frontiers Editorial Office ^*

Frontiers Media SA, Lausanne, Switzerland

This article is a retraction of:

Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction
1. Read original article

The final, formatted version of the article will be published soon.

Please find the retraction notice below:Mao S, Vincent M, Chen M, Zhang M and Hinek A (2019) Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction. Front. Pharmacol. 10:779. doi: 10.3389/fphar.2019.00779 The journal retracts the article cited above. Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication was identified between Figure 6B and 7B. Some panels of Figure 3C, 6B and 9B were also found to be published in other articles. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted. This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. MV agrees to this retraction. SM, MC, MZ and AH did not respond to correspondence regarding this retraction. Frontiers would like to thank the users on PubPeer for bringing the published article to our attention.

Keywords: Sodium tanshinone IIA sulfonate, cardiac remodeling, Autophagy, Apoptosis, AMP Kinase pathway

Received: 12 Feb 2025; Accepted: 12 Feb 2025.

Copyright: © 2025 Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.